Cellectar Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Cellectar Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Cellectar Biosciences Inc
Rating: 0.75608325
Author: Trendlyne DVM scores

about

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

2.56 -0.20 (-7.25%)

Near 52W Low of $2.45

110.7K

XNAS Volume

XNAS 26 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

11.8 / 100

Technically Bearish

18.4 / 100

No estimates available

Cellectar Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cellectar Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

Near 52W Low of $2.45

SWOT Analysis

Cellectar Biosciences Inc Live Price Chart